Real-time Estimate
Other stock markets
|
|
5-day change | 1st Jan Change | |
28.52 USD | -0.92% | -2.53% | -44.30% |
Dec. 08 | Sector Update: Health Care Stocks Rise Late Afternoon | MT |
Dec. 08 | Sector Update: Health Care Stocks Steady in Afternoon Trading | MT |
Pfizer, Inc. the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- vaccines (52.4%);
- drugs for the treatment of cancer (15.2%);
- cardiovascular, metabolic and analgesic drugs (11.5%);
- injectable, anti-infectives drugs and active pharmaceutical ingredients (9%);
- drugs for inflammatory and immune diseases (5.5%);
- drugs for rare diseases (4.4%);
- other (2%).
At the end of 2021, the group had more than 39 production sites worldwide.
Net sales are distributed geographically as follows: the United States (36.6%), Europe (22.6%) and other (40.8%).
Sector
Pharmaceuticals
Calendar
Trading Rating :
Investor Rating :
ESG Refinitiv :
C+
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.78USD
Average target price
40.41USD
Spread / Average Target
+40.42%
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.30% | 163 B $ | |
+58.30% | 538 B $ | |
+42.69% | 430 B $ | |
-12.46% | 372 B $ | |
-6.24% | 264 B $ | |
-5.98% | 263 B $ | |
-12.46% | 232 B $ | |
+2.38% | 198 B $ | |
+3.47% | 144 B $ | |
-2.27% | 116 B $ |
- Stock
- Equities
- Stock Pfizer, Inc. - Nyse
- News Pfizer, Inc.
- Pfizer's Rocky Mount, North Carolina, Facility Restarts Majority of Production After July Tornado